IP Group plc (LSE: IPO), the world’s leading intellectual property commercialization company, announced the opening of its Greater China headquarter in Hong Kong during the Group’s ‘Global Deep Tech Forum’ event held at the Hong Kong Stock Exchange.
Alan Aubrey, Chief Executive of IP Group plc, said: “IP Group is committed to working with partners in Asia and in particular China to support the growth of its portfolio companies with exposure to one of the world’s most dynamic economies. Hong Kong is the ideal gateway for IP Group to fulfill its ambition for the Greater China market with its well-developed capital market, world-class legal system, and increasing focus on innovation & technology. IP Group and its portfolio companies will benefit from the fast-growing market as well as the well-established supply chain of the Greater China area. We consider this region to be strategically important and will continue to facilitate partnership discussions between our portfolio companies and relevant local parties.”
IP Group plc, which is headquartered in London, has partnered with leading universities and research institutions in the UK, the US and Australasia to help commercialize their intellectual property. The Group’s portfolio, which was valued at c£1.1bn at 30 June 2018, comprises over 150 companies and covers a broad range of innovations across life sciences and technology. Many of the Group’s UK portfolio companies have secured investment and business partnerships in Greater China, including Oxford Nanopore Technologies, Ceres Power, Mirriad Advertising and Creavo Medical Technologies. The Group’s largest holding, Oxford Nanopore Technologies, which provides novel DNA/RNA sequencing technology, completed a £100m fundraising primarily from Asian investors earlier this year.
About IP Group IP Group plc is a leading intellectual property commercialization company focused on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital, networks, recruitment, and business support. IP Group has a strong track record of success, and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.